Kiran Mazumdar Shaw, MD, Biocon says Narayana Murthy's return would have probably been a tough decision, as most succession plans are and will undoubtedly help boost investor and employee confidence.
first published: Jun 1, 2013 04:23 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

